Legend Biotech ROE - Return on Equity 2019-2024 | LEGN

Legend Biotech return on equity for the quarter ending September 30, 2024 was -24.93.

  • Legend Biotech average return on equity for 2023 was -90.82, a 0.2% decline from 2022.
  • Legend Biotech average return on equity for 2022 was -91, a 19.95% decline from 2021.
  • Legend Biotech average return on equity for 2021 was -113.68, a 60.8% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Legend Biotech ROE - Return on Equity 2019-2024 | LEGN

  • Legend Biotech average return on equity for 2023 was -90.82, a 0.2% decline from 2022.
  • Legend Biotech average return on equity for 2022 was -91, a 19.95% decline from 2021.
  • Legend Biotech average return on equity for 2021 was -113.68, a 60.8% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.